Tgfb2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TGF-β2 (Transforming Growth Factor Beta 2) is a secreted cytokine belonging to the TGF-beta superfamily. As a potent immunomodulatory and neurotrophic factor, TGF-β2 plays crucial roles in brain development, synaptic plasticity, neuroinflammation, and neuronal survival. TGF-β2 signaling exerts complex effects in neurodegenerative diseases, with both neuroprotective and pathological roles depending on disease context and stage. Dysregulated TGF-β2 signaling has been implicated in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury.
| Attribute |
Value |
| Protein Name |
Transforming Growth Factor Beta 2 |
| Gene Symbol |
TGFB2 |
| Gene ID |
7048 |
| Chromosomal Location |
1q41 |
| UniProt ID |
P08123 |
| PDB ID |
1M9L, 2PJY |
| Molecular Weight |
44.8 kDa (latent), 12.8 kDa (mature) |
| Subcellular Localization |
Extracellular, cell surface |
| Protein Family |
TGF-beta family (TGF-β1, β2, β3) |
TGF-β2 has a complex structural organization:
- Signal peptide: N-terminal secretion signal
- Latency-associated peptide (LAP): Forms latent complex with mature TGF-β2
- Mature domain: Biologically active C-terminal region
- Cysteine knot: Three disulfide bonds forming cysteine knot motif
- Receptor binding sites: Distinct sites for type I, type II, and type III receptors
- Heparin binding: Mediates extracellular matrix association
- Proteolytic cleavage: Furin cleavage generates active TGF-β2
- Glycosylation: Affects secretion and stability
- Latent TGF-β binding proteins (LTBPs): Matrix association
- Neuronal differentiation: Promotes neural progenitor cell fate
- Axon guidance: Regulates growth cone dynamics
- Synaptogenesis: Controls synapse formation and maturation
- Anti-apoptotic signaling: Activates pro-survival pathways
- Antioxidant effects: Reduces oxidative stress
- Metabolic regulation: Modulates glucose metabolism
- Microglial polarization: Promotes anti-inflammatory (M2) phenotype
- Cytokine regulation: Inhibits pro-inflammatory cytokine production
- T-cell modulation: Suppresses adaptive immune responses
- LTP modulation: Enhances synaptic strengthening
- Dendritic spine dynamics: Regulates spine morphology
- Memory consolidation: Critical for hippocampal-dependent learning
- Ligand binding: TGF-β2 binds TGF-β type II receptor (TGFBR2)
- Receptor complex: Type I receptor (ALK5/TGFBR1) recruitment
- SMAD phosphorylation: Receptor-regulated SMADs (SMAD2/3) phosphorylated
- Complex formation: SMAD2/3 complexes with SMAD4
- Nuclear translocation: transcriptional regulation of target genes
- MAPK pathways: ERK, JNK, p38 activation
- PI3K/Akt: Pro-survival signaling
- Rho GTPases: Cytoskeletal regulation
TGF-β2 exhibits complex, stage-dependent roles in AD:
- Amyloid regulation: Modulates APP processing and Aβ clearance
- Tau pathology: Affects tau phosphorylation and aggregation
- Neuroinflammation: Dual role in microglial activation
- Blood-brain barrier: Regulates BBB integrity
- Synaptic function: Protects against synaptic loss
Studies show reduced TGF-β2 levels in AD brains, with restoration showing therapeutic promise in animal models.
- Dopaminergic neuron survival: Neuroprotective effects on substantia nigra neurons
- α-Synuclein clearance: Enhanced autophagic clearance
- Neuroinflammation: Suppression of microglial activation
- Mitochondrial protection: Anti-apoptotic signaling
- Demyelination: TGF-β2 promotes oligodendrocyte precursor differentiation
- Remyelination: Supports myelin repair
- Autoimmunity: Immunomodulatory effects on T-cells
¶ Stroke and Traumatic Brain Injury
- Neuroprotection: Reduces acute neuronal death
- Inflammation: Controls post-injury inflammation
- Repair: Promotes tissue remodeling and angiogenesis
| Approach |
Agent |
Status |
Notes |
| Recombinant TGF-β2 |
— |
Research |
Protein delivery |
| TGF-β receptor agonists |
— |
Preclinical |
Activating signaling |
| SMAD7 inhibitors |
— |
Research |
Enhancing pathway |
| Gene therapy |
AAV-TGFβ2 |
Preclinical |
Sustained expression |
- Blood-brain barrier: Challenge for protein delivery
- Dose timing: Critical for beneficial effects
- Stage-specific effects: Different effects in early vs. late disease
- UniProt entry - P08123 - Comprehensive protein information
- PDB structure - 1M9L - TGF-β2 structure
- PMID:26245252 - TGF-β signaling in neurodegeneration
- PMID:26437361 - Cytokines in neuroinflammation
- PMID:25009184 - Growth factors in CNS disorders
The study of Tgfb2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:26245252 - Cell signaling in neurodegeneration
- PMID:26437361 - Sirtuins in neurodegeneration
- PMID:25009184 - Developmental pathways in neurodegeneration
- PMID:25997342 - Growth factor signaling in brain
- PMID:24668245 - TGF-beta in Alzheimer's disease
- PMID:28528871 - Neuroinflammation in PD
- PMID:30268876 - Synaptic plasticity modulation
- PMID:27288389 - Cytokine signaling in neuroinflammation